321 related articles for article (PubMed ID: 15716361)
1. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.
Fornai F; Schlüter OM; Lenzi P; Gesi M; Ruffoli R; Ferrucci M; Lazzeri G; Busceti CL; Pontarelli F; Battaglia G; Pellegrini A; Nicoletti F; Ruggieri S; Paparelli A; Südhof TC
Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3413-8. PubMed ID: 15716361
[TBL] [Abstract][Full Text] [Related]
2. Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity.
Fornai F; Lazzeri G; Bandettini Di Poggio A; Soldani P; De Blasi A; Nicoletti F; Ruggieri S; Paparelli A
Ann N Y Acad Sci; 2006 Aug; 1074():84-9. PubMed ID: 17105905
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
[TBL] [Abstract][Full Text] [Related]
4. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
Dong Z; Ferger B; Feldon J; Büeler H
J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
[TBL] [Abstract][Full Text] [Related]
6. Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Przedborski S; Chen Q; Vila M; Giasson BI; Djaldatti R; Vukosavic S; Souza JM; Jackson-Lewis V; Lee VM; Ischiropoulos H
J Neurochem; 2001 Jan; 76(2):637-40. PubMed ID: 11208927
[TBL] [Abstract][Full Text] [Related]
7. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Schlüter OM; Fornai F; Alessandrí MG; Takamori S; Geppert M; Jahn R; Südhof TC
Neuroscience; 2003; 118(4):985-1002. PubMed ID: 12732244
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease.
Meredith GE; Totterdell S; Petroske E; Santa Cruz K; Callison RC; Lau YS
Brain Res; 2002 Nov; 956(1):156-65. PubMed ID: 12426058
[TBL] [Abstract][Full Text] [Related]
9. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F
J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163
[TBL] [Abstract][Full Text] [Related]
10. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
[TBL] [Abstract][Full Text] [Related]
11. Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid.
Alvarez-Fischer D; Guerreiro S; Hunot S; Saurini F; Marien M; Sokoloff P; Hirsch EC; Hartmann A; Michel PP
J Neurochem; 2008 Nov; 107(3):701-11. PubMed ID: 18761710
[TBL] [Abstract][Full Text] [Related]
12. Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease.
Shimoji M; Zhang L; Mandir AS; Dawson VL; Dawson TM
Brain Res Mol Brain Res; 2005 Mar; 134(1):103-8. PubMed ID: 15790534
[TBL] [Abstract][Full Text] [Related]
13. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
Mandel S; Maor G; Youdim MB
J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262
[TBL] [Abstract][Full Text] [Related]
14. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
15. Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.
Rekha KR; Selvakumar GP; Santha K; Inmozhi Sivakamasundari R
Biochem Biophys Res Commun; 2013 Nov; 440(4):664-70. PubMed ID: 24103762
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
[TBL] [Abstract][Full Text] [Related]
17. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
[TBL] [Abstract][Full Text] [Related]
18. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.
Song DD; Shults CW; Sisk A; Rockenstein E; Masliah E
Exp Neurol; 2004 Apr; 186(2):158-72. PubMed ID: 15026254
[TBL] [Abstract][Full Text] [Related]
19. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
[TBL] [Abstract][Full Text] [Related]
20. Acupuncture Inhibits the Increase in Alpha-Synuclein by Modulating SGK1 in an MPTP Induced Parkinsonism Mouse Model.
Yeo S; Lim S
Am J Chin Med; 2019; 47(3):527-539. PubMed ID: 30966771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
